The apparent trend of association between stage II and high CES in TCGA breast cancer data set is primarily due to enrichment of basal-like and HER2+ subtypes in stage II compared with stage I tumours (Supplementary Fig. 8; Supplementary Table 11). The gene discussed is ERBB2; the disease is breast carcinoma.